Intravascular devices and fibrosis-inducing agents
0 Assignments
0 Petitions
Accused Products
Abstract
Intravascular devices (e.g., stents, stent grafts, covered stents, aneurysm coils, embolic agents and drug delivery catheters and balloons) are used in combination with fibrosing agents in order to induce fibrosis that may otherwise not occur when the implant is placed within an animal or to promote fibrosis betweent the devices and the host tissues. Compositions and methods are described for use in the treatment of aneurysms and unstable arterial (vulnerable) plaque.
-
Citations
329 Claims
-
1-195. -195. (canceled)
-
196. A method of inducing fibrosis, comprising:
implanting into a lumen of a blood vessel in a patient in need thereof a device, wherein the device comprises an intravascular device and a fibrosing agent or a composition comprising a fibrosing agent, wherein the device is configured to locally deliver the fibrosing agent or the composition comprising the fibrosing agent to a tissue in the vicinity of the implanted device, wherein the fibrosing agent induces a fibrotic response between the device and the patient in which the device is implanted. - View Dependent Claims (197, 198, 199, 200, 201, 210, 217, 218, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 324, 325, 328)
-
202-209. -209. (canceled)
-
211-216. -216. (canceled)
-
219-288. -288. (canceled)
-
322. (canceled)
-
323. (canceled)
-
326. (canceled)
-
327. (canceled)
-
329-1738. -1738. (canceled)
Specification